Nanotech improves cystic fibrosis antibiotic by 100,000-fold
World first nanotech developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis.
Browsing Tag
Antibiotic
Distinguishing resistance from resilience to prolong antibiotic potency
Lingchong You, Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke University. Credit: Duke Photography
Biomedical engineers at…
8,000 new antibiotic combinations are surprisingly effective | Digital…
Scientists have traditionally believed that combining more than two drugs to fight harmful bacteria would yield diminishing returns. The prevailing theory is…
8,000 new antibiotic combinations are surprisingly effective, biologists…
“We shouldn’t limit ourselves to just single drugs or two-drug combinations in our medical toolbox,” said Pamela Yeh (left), with Elif Tekin. Credit: Reed…
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3 |…
Entasis Therapeutics has filed to raise up to $86 million through an IPO. The AstraZeneca spinout is seeking the money to fund a phase 3 trial of a drug to…
Researchers Developed Light-Activated Nanoparticles That Kill 90% of…
In Brief
Scientists used quantum dots to make bacteria killing nanoparticles that are 20,000 times smaller than a strand of human hair, and they…